Cargando…
Targeting PTB for Glia-to-Neuron Reprogramming In Vitro and In Vivo for Therapeutic Development in Neurological Diseases
In vivo cell reprogramming of glial cells offers a promising way to generate new neurons in the adult mammalian nervous system. This approach might compensate for neuronal loss occurring in neurological disorders, but clinically viable tools are needed to advance this strategy from bench to bedside....
Autores principales: | Contardo, Matilde, De Gioia, Roberta, Gagliardi, Delia, Comi, Giacomo Pietro, Ottoboni, Linda, Nizzardo, Monica, Corti, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962309/ https://www.ncbi.nlm.nih.gov/pubmed/35203608 http://dx.doi.org/10.3390/biomedicines10020399 |
Ejemplares similares
-
Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
por: Gagliardi, Delia, et al.
Publicado: (2022) -
Animal Models of CMT2A: State-of-art and Therapeutic Implications
por: De Gioia, Roberta, et al.
Publicado: (2020) -
Direct reprogramming of human astrocytes into neural stem cells and neurons
por: Corti, Stefania, et al.
Publicado: (2012) -
Neural Stem Cell Transplantation for Neurodegenerative Diseases
por: De Gioia, Roberta, et al.
Publicado: (2020) -
Extracellular vesicles and amyotrophic lateral sclerosis: from misfolded protein vehicles to promising clinical biomarkers
por: Gagliardi, Delia, et al.
Publicado: (2020)